Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRA

Multiplicity Considerations in Clinical Trials

(2018) Alex Dmitrienko et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rheumatoid arthritis

(2018) Josef S. Smolen et al.   Nature Reviews Disease Primers

The use of glucocorticoids in early rheumatoid arthritis

(2017) Patrick Verschueren et al.   RHEUMATOLOGY

Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial

(2016) Patrick Verschueren et al.   ANNALS OF THE RHEUMATIC DISEASES

Rheumatologists’ adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission

(2016) G. Akdemir et al.   CLINICAL RHEUMATOLOGY

Linear extrapolation of missing radiographic change scores in clinical trials does not spuriously overestimate group radiographic changes in rheumatoid arthritis

(2016) Iris M. Markusse et al.   RHEUMATOLOGY

Unraveling Patient-Preferred Health and Treatment Outcomes in Early Rheumatoid Arthritis: A Longitudinal Qualitative Study

(2016) Kristien van der Elst et al.   ARTHRITIS CARE & RESEARCH

Patient experiences with intensive combination-treatment strategies with glucocorticoids for early rheumatoid arthritis

(2015) Sabrina Meyfroidt et al.   PATIENT EDUCATION AND COUNSELING

Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial

(2015) Patrick Verschueren et al.   ARTHRITIS RESEARCH & THERAPY

Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial

(2014) Marieke M ter Wee et al.   ANNALS OF THE RHEUMATIC DISEASES

Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial

(2014) P Verschueren et al.   ANNALS OF THE RHEUMATIC DISEASES

What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review

(2013) J A B van Nies et al.   ANNALS OF THE RHEUMATIC DISEASES

A non-inferiority trial of an attenuated combination strategy (‘COBRA-light’) compared to the original COBRA strategy: clinical results after 26 weeks

(2013) Debby den Uyl et al.   ANNALS OF THE RHEUMATIC DISEASES

Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial

(2012) P H de Jong et al.   ANNALS OF THE RHEUMATIC DISEASES

Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score With 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Cl

(2011) Jaclyn K. Anderson et al.   ARTHRITIS CARE & RESEARCH